
Dec 18 (Reuters) - Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial intelligence, succeeded in two late-stage studies.
More than half the plaque psoriasis patients across the studies showed clear or almost clear skin after 16 weeks of treatment with the once-daily drug, zasocitinib, the company said.
Takeda plans to file marketing applications with the U.S. Food and Drug Administration and other regulatory authorities in 2026.
If approved, zasocitinib would join a crowded plaque psoriasis market featuring well-established oral rivals like Bristol Myers' Sotyktu and Amgen's Otezla, plus injectables including Johnson & Johnson's Tremfya, AbbVie's Skyrizi, and Novartis' Cosentyx.
Takeda's pill offers a convenient daily pill alternative alongside Sotyktu and Otezla in a market dominated by injectable drugs for treating plaque psoriasis, in which red, scaly patches occur on the skin due to an overactive immune system.
The company is banking on the blockbuster potential of zasocitinib to help fill a revenue gap it faces after its inflammatory bowel disease drug Entyvio loses key patents at the end of the decade.
Takeda in January had said it expects zasocitinib, if approved, to generate peak annual sales in the range of $3 billion to $6 billion.
The drugmaker acquired zasocitinib from drug developer Nimbus Therapeutics in 2022 in a deal worth up to $6 billion. Nimbus had identified the compound with the help of AI, a trend picking up pace in the pharmaceutical industry as companies seek to accelerate development of medicines.
The drug was generally well tolerated and outperformed placebo and Amgen's Otezla, with treatment responses strengthening through week 24.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Vote in favor of Your #1 BWM Vehicles - 2
Pedal Power: Divulging Well known Bike Brands for Each Cyclist - 3
A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one - 4
RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record - 5
The most effective method to Guarantee Simple Availability in Seniors' SUVs
Discussion on deployment of foreign troops ongoing, two sources tell 'Post'
Changing Negative Cash Mentalities: Enabling Your Monetary Excursion
German foreign minister heads to China to talk rare-earth exports
Interoceanic Train derails in southern Mexico, injuring at least 15 and halting traffic on line
Josh Duhamel's secret to the good life at 53? Wolverine peptides, ditching Hollywood and having another baby.
Our 10 favorite Space.com reader astronomy photos of 2025
False fuel prices in fabricated graphics circulate in Malaysia as Iran war continues
Tech for Efficiency: Applications and Apparatuses to Accomplish More
The Best 20 Tunes that Characterized an Age












